Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$74.2K Buy
431
+2
+0.5% +$334 0.01% 126
2026
Q1
$74.4K Buy
429
+2
+0.5% +$360 0.01% 121
2025
Q4
$79.3K Hold
427
0.02% 118
2025
Q3
$77.2K Buy
427
+4
+0.9% +$823 0.02% 124
2025
Q2
$90.5K Sell
423
-26
-6% -$5.87K 0.02% 114
2025
Q1
$107K Buy
449
+29
+7% +$6.58K 0.03% 99
2024
Q4
$88.7K Sell
420
-14
-3% -$3.11K 0.02% 106
2024
Q3
$98.9K Buy
434
+17
+4% +$3.77K 0.02% 102
2024
Q2
$88.7K Hold
417
0.02% 101
2024
Q1
$87.1K Buy
417
+57
+16% +$11.4K 0.02% 102
2023
Q4
$70.4K Buy
360
+1
+0.3% +$193 0.02% 119
2023
Q3
$69.3K Buy
359
+2
+0.6% +$383 0.03% 117
2023
Q2
$66.2K Buy
357
+1
+0.3% +$177 0.03% 123
2023
Q1
$59.3K Buy
356
+1
+0.3% +$167 0.03% 137
2022
Q4
$59K Buy
355
+1
+0.3% +$164 0.03% 137
2022
Q3
$54K Buy
354
+2
+0.6% +$321 0.03% 137
2022
Q2
$55K Buy
352
+1
+0.3% +$160 0.04% 141
2022
Q1
$53K Hold
351
0.03% 153
2021
Q4
$53K Buy
351
+2
+0.6% +$332 0.03% 153
2021
Q3
$58K Buy
+349
New +$52.8K 0.03% 147

Other funds holding MRSH

Kozak & Associates's MRSH Position: Q2 2026 in Review

Kozak & Associates increased its Marsh (MRSH) stake by 0.47% in Q2 2026, buying an estimated $334 and bringing the position to 431 shares worth $74.2K. The position accounts for 0.01% of the portfolio, ranked #126.

Kozak & Associates first reported a position in MRSH in Q3 2021 and has held it in 20 quarters since. The position peaked at $107K in Q1 2025. 1,498 funds tracked by Wall St. Rank hold MRSH as of Q2 2026.

  • Kozak & Associates held 431 shares of Marsh worth $74.2K as of Q2 2026.
  • Kozak & Associates bought 2 Marsh shares in Q2 2026, an estimated $334.
  • Marsh made up 0.01% of Kozak & Associates's portfolio in Q2 2026, its #126 holding.
  • Kozak & Associates first reported a position in Marsh in Q3 2021 and has held it in 20 quarters since.
  • Kozak & Associates's Marsh position peaked at $107K in Q1 2025.
  • 1,498 funds tracked by Wall St. Rank held Marsh as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.